Stay updated on Atezolizumab Combo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combo in Ovarian Cancer Clinical Trial page.

Latest updates to the Atezolizumab Combo in Ovarian Cancer Clinical Trial page
- ChecktodayChange DetectedThe page’s displayed software/revision number has been updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a minor platform/version release. No study record fields or substantive clinical information are shown as changed.SummaryDifference0.1%

- Check7 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history log.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check36 days agoChange DetectedNew revision entry v3.5.0 added and revision v3.4.3 removed from the record history.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 in the page history.SummaryDifference0.1%

- Check72 days agoChange DetectedA new Revision: v3.4.2 entry was added, and the older government-funding notice was removed.SummaryDifference0.4%

- Check79 days agoChange DetectedA notice about a lapse in government funding was added, informing users that information may not be up to date and directing them to cc.nih.gov and opm.gov for status updates. The revision version changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Atezolizumab Combo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combo in Ovarian Cancer Clinical Trial page.